CATALANO, Antonino
 Distribuzione geografica
Continente #
EU - Europa 11.498
NA - Nord America 8.448
AS - Asia 5.959
SA - Sud America 2.018
AF - Africa 182
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.121
Nazione #
US - Stati Uniti d'America 8.264
RU - Federazione Russa 6.333
SG - Singapore 2.554
BR - Brasile 1.686
CN - Cina 1.665
IE - Irlanda 1.335
SE - Svezia 1.108
IT - Italia 902
HK - Hong Kong 661
DE - Germania 486
FR - Francia 419
VN - Vietnam 350
FI - Finlandia 219
IN - India 196
GB - Regno Unito 174
PL - Polonia 167
AR - Argentina 119
CA - Canada 81
IQ - Iraq 72
UA - Ucraina 71
EC - Ecuador 64
TR - Turchia 63
MX - Messico 62
NL - Olanda 58
BD - Bangladesh 55
AT - Austria 51
ZA - Sudafrica 49
PK - Pakistan 42
ES - Italia 37
JP - Giappone 36
BE - Belgio 34
CO - Colombia 33
VE - Venezuela 32
ID - Indonesia 30
UZ - Uzbekistan 29
CL - Cile 27
JO - Giordania 25
MA - Marocco 24
CI - Costa d'Avorio 22
EG - Egitto 22
PY - Paraguay 22
PH - Filippine 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 16
KR - Corea 15
KE - Kenya 14
AZ - Azerbaigian 13
LT - Lituania 13
MY - Malesia 13
PE - Perù 13
IL - Israele 12
NP - Nepal 12
TN - Tunisia 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
CH - Svizzera 11
AU - Australia 10
DO - Repubblica Dominicana 10
DZ - Algeria 9
BO - Bolivia 8
HN - Honduras 8
KG - Kirghizistan 8
NO - Norvegia 8
RO - Romania 8
BG - Bulgaria 7
ET - Etiopia 7
JM - Giamaica 7
KZ - Kazakistan 7
NG - Nigeria 7
OM - Oman 7
AL - Albania 6
BH - Bahrain 6
CU - Cuba 6
SN - Senegal 6
TH - Thailandia 6
EE - Estonia 5
LV - Lettonia 5
GE - Georgia 4
GR - Grecia 4
IR - Iran 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
GT - Guatemala 3
LB - Libano 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GY - Guiana 2
HU - Ungheria 2
KW - Kuwait 2
Totale 28.098
Città #
Moscow 1.732
Ashburn 1.461
Singapore 1.375
Dublin 1.334
Dallas 921
Chandler 911
Hong Kong 620
Nyköping 596
Beijing 555
San Jose 400
The Dalles 307
Messina 301
Jacksonville 261
Princeton 237
Dearborn 227
Munich 207
Lauterbourg 191
New York 189
Los Angeles 187
Medford 175
Warsaw 155
São Paulo 137
Ann Arbor 136
Ho Chi Minh City 128
Des Moines 127
Cambridge 120
Boardman 108
Bremen 101
Catania 90
Buffalo 87
Turku 76
Redondo Beach 73
Guangzhou 70
Tianjin 68
Jinan 65
Shenyang 65
Wilmington 65
Frankfurt am Main 63
Hanoi 62
Orem 57
Santa Clara 57
Pune 50
San Mateo 47
Belo Horizonte 44
Nanjing 44
Curitiba 42
Seattle 42
Chennai 41
Rio de Janeiro 41
Helsinki 40
Council Bluffs 39
Houston 39
Nuremberg 35
Brussels 34
Montreal 31
Porto Alegre 31
Brasília 30
Brooklyn 30
Hebei 30
Tokyo 29
Baghdad 28
Chicago 28
Zhengzhou 28
Düsseldorf 27
Johannesburg 27
Vienna 27
Haikou 26
London 26
Nanchang 26
Rome 26
Taizhou 26
Amsterdam 25
Hangzhou 25
Strasbourg 25
Ningbo 24
Woodbridge 24
Atlanta 23
Milan 23
Tashkent 23
Abidjan 22
Boston 22
Denver 22
Shanghai 22
Amman 21
Falls Church 21
Goiânia 21
Poplar 21
Quito 21
Manchester 20
Guayaquil 19
Hyderabad 19
Lancaster 19
Mumbai 18
Mexico City 17
San Francisco 17
Stockholm 17
Toronto 17
Fremont 16
Fuzhou 16
Changsha 15
Totale 15.706
Nome #
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 235
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 223
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 220
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 217
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 216
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 216
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 214
A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of L-thyroxine, may have metabolic and cardiovascular consequences 213
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 212
A clinical bridge between family caregivers and older adults: The contribution of patients’ frailty and optimism on caregiver burden 210
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 209
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 206
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 205
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 204
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 200
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 197
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 193
Association between cognitive reserve dimensions and frailty among older adults: A structured narrative review 192
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 191
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 187
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 187
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 187
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 186
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 186
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 185
Hyponatremia as a leading sign of hypopituitarism 184
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 183
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 179
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 178
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 178
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 176
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 174
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 171
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 170
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 170
Association between anxiety levels and osteoporosis in postmenopausal women. 169
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 166
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 165
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 164
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 163
Anxiety levels as risk factor for osteoporosis in postmenopausal women 163
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 163
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 163
Alexithymia and asthma: a systematic review 163
Frailty and lipid profile in elderly hospitalized patients 162
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 161
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 160
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 158
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 158
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 157
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 156
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 155
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 155
Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate 154
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 153
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 153
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 153
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 153
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 152
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 152
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 151
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 151
Frailty modifications and prognostic impact in older patients admitted in acute care 151
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 148
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 148
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 148
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 148
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 146
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 146
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 145
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 145
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 145
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 145
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 144
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 144
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 143
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 143
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 143
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 143
Relationship between blood pressure and frailty in older hypertensive outpatients 143
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 143
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 142
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link? 140
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 140
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 140
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 140
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 138
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 138
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 137
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 137
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 136
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 136
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 136
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 136
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study 136
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 135
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 135
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 135
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 134
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 134
Totale 16.493
Categoria #
all - tutte 90.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021189 0 0 0 0 0 0 0 0 0 109 31 49
2021/20221.567 13 134 23 60 43 22 150 52 152 298 124 496
2022/20233.707 277 378 179 232 298 332 36 178 1.597 48 115 37
2023/20241.116 76 160 54 127 77 246 37 93 4 41 31 170
2024/20254.890 85 73 94 333 244 166 131 931 1.159 372 440 862
2025/202614.567 783 1.049 1.010 1.035 1.304 3.032 1.818 2.042 1.932 562 0 0
Totale 28.722